Replies to post #72874 on Biotech Values

[DewDiligence]

NVS might not be the only co. interested in IDIX.

NVS owns 56% of IDIX’s shares so, realistically, there can’t be another serious suitor for IDIX. The situation is analogous to Roche-DNA, on a much smaller scale, of course.